{"created":"2023-07-27T06:38:37.970683+00:00","id":26766,"links":{},"metadata":{"_buckets":{"deposit":"52d1dcb6-5ea1-4357-b614-4a1c8bfed13c"},"_deposit":{"created_by":3,"id":"26766","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"26766"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00026766","sets":["1761:1762:1763"]},"author_link":["45190","1205","463","264","45192","115","45191"],"item_4_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2011-10-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"10","bibliographicPageEnd":"946","bibliographicPageStart":"941","bibliographicVolumeNumber":"32","bibliographic_titles":[{"bibliographic_title":"Nuclear Medicine Communications"}]}]},"item_4_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"OBJECTIVE: We assessed the lesion detectability of low-dose diagnostic 123I-metaiodobenzylguanidine (MIBG) whole-body scans obtained at 6 and 24 h compared with posttreatment 131I-MIBG whole-body scans in malignant pheochromocytoma and paraganglioma. METHODS: Scintigrams obtained in 15 patients with malignant pheochromocytoma and paraganglioma were retrospectively analyzed. Diagnostic scans were performed with 111 MBq of 123I-MIBG. Therapeutic doses of 131I-MIBG (5.55-7.40 GBq) were administrated and whole-body scans were obtained at 2-5 days after 123I-MIBG administrations. We compared the number of lesions and the lesion-to-referent count ratios at 6 and 24 h of 123I-MIBG and at 2-5 days of 131I-MIBG. RESULTS: In comparison with the 6-h images of 123I-MIBG, the 24-h images of 123I-MIBG could detect more lesions in eight patients. Posttreatment 131I-MIBG scans revealed new lesions in eight patients compared with the 24-h images of 123I- MIBG. The lesion-to-referent count ratios at 6 and 24 h of 131I-MIBG and at 3 days of 131I-MIBG were increasing at later scanning time. There were significant differences in the lesion-to-referent count ratios between 6 and 24 h of 123I-MIBG (P=0.031), 6 h of 131I-MIBG and 3 days of 123I-MIBG (P=0.020), and 24 h of 123I-MIBG and 3 days of 131I-MIBG (P=0.018). CONCLUSION: Low-dose diagnostic 123I-MIBG whole-body scan is inferior to posttreatment 131I-MIBG whole-body scan in malignant pheochromocytoma and paraganglioma. Considering the scan timing of 123I-MIBG, 6-h images might have no superiority compared with 24-h images. © 2011 Wolters Kluwer Health | Lippincott Williams &Wilkins.","subitem_description_type":"Abstract"}]},"item_4_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Lippincott, Williams & Wilkins"}]},"item_4_relation_12":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1097/MNM.0b013e32834a4445","subitem_relation_type_select":"DOI"}}]},"item_4_source_id_11":{"attribute_name":"NCID","attribute_value_mlt":[{"subitem_source_identifier":"AA10624879","subitem_source_identifier_type":"NCID"}]},"item_4_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0143-3636","subitem_source_identifier_type":"ISSN"}]},"item_4_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Kayano, Daiki"}],"nameIdentifiers":[{},{},{}]},{"creatorNames":[{"creatorName":"Taki, Junichi"}],"nameIdentifiers":[{},{},{},{}]},{"creatorNames":[{"creatorName":"Fukuoka, Makoto"}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"Wakabayashi, Hiroshi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Inaki, Anri"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Nakamura, Ayane"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kinuya, Seigo"}],"nameIdentifiers":[{},{},{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-05"}],"displaytype":"detail","filename":"HO-PR-KAYANO-D-941.pdf","filesize":[{"value":"547.2 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"HO-PR-KAYANO-D-941.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/26766/files/HO-PR-KAYANO-D-941.pdf"},"version_id":"a1dd5221-b8c1-4248-9812-e8c03fbef724"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma"}]},"item_type_id":"4","owner":"3","path":["1763"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-05"},"publish_date":"2017-10-05","publish_status":"0","recid":"26766","relation_version_is_last":true,"title":["Low-dose 123I-metaiodobenzylguanidine diagnostic scan is inferior to 131I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paraganglioma"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-07-27T21:19:15.426837+00:00"}